Central, Extraventricular and Atypical Neurocytomas: a Clinicopathologic Study of 35 Cases from Pakistan Plus a Detailed Review of the Published Literature

  • Ahmad, Zubair ;
  • Din, Nasir Ud ;
  • Memon, Aisha ;
  • Tariq, Mohammad Usman ;
  • Idrees, Romana ;
  • Hasan, Sheema
  • Published : 2016.04.11


Background: Central neurocytomas are rare neuronal neoplasms with a favorable prognosis. They are typically located in the lateral ventricles of the brain and mostly histologically correspond to WHO grade II with a Mib 1 labelling index of <2%. Similar tumors located in the cerebral hemispheres and spinal cord, for example, are called "extraventricular neurocytomas". A few tumors histologically show atypia, mitoses, vascular proliferation and/or necrosis and a Mib 1 index >2 % and are designated as "atypical neurocytomas. Aim: The aim of our study was to describe the common as well as unusual morphologic features and the role of various immunohistochemical stains in the diagnosis of these rare tumors. Materials and Methods: We retrieved and reviewed 35 cases diagnosed between 2001 and 2015. Results: Sixty percent of patients were males, and the mean age was 26 years. 31 cases (88.6%) were intraventricular and 4(11.4%) were extraventricular. Histologically, 6 cases (17.1%) were compatible with "atypical neurocytomas". All cases showed the classic morphology comprising nests and sheets of uniform, round cells with uniform round to oval nuclei with finely speckled chromatin and perinuclear cytoplasmic clearing (halos). All cases also showed delicate, fibrillary, neuropil-like matrices. Other common histologic features included capillary-sized blood vessels in a branching pattern in 57.1%, foci of calcification in 34.3% and perivascular pseudorosettes in 20%. Rare findings included Homer-Wright or true rosettes in 8.6% and ganglioid cells in 2.9%. Synaptophysin was the most consistent and valuable marker, being positive in almost all cases. GFAP positivity in tumor cells was seen in 25.7% of cases. Follow up was available in 13 patients. Of these 9 had histologically typical and 4 had atypical tumors. Only 1 (with an atypical neurocytoma) died, probably due to complications of surgery within one month, while 12 (including 3 with atypical neurocytomas) remained alive. Recurrence developed in 1 of these 12 patients (histologically consistent with typical morphology) almost 9 years after surgery. Only 4 patients, including 2 with atypical tumors, received postoperative radiotherapy, all with surgery in 2010 or later. Overall, prognosis was excellent with prolonged, recurrence free survival and most patients, even without receiving radiation therapy, were alive and well for many years, even a decade or more after surgery, without developing any recurrence, indicating the benign nature of these neoplasms.


Central neurocytoma;intraventicular;extraventricular;typical;atypical;synaptophysin


  1. Ahmad Z, Arshad H, Hasan S, et al (2010). CNS neoplasms in Pakistan, a pathological perspective. Asian Pac J Cancer Prev, 12, 317-21.
  2. Atalay T, Ak Hakan, Celik B, et al (2015). Prognostic factors in oligodendrogliomas: a clinical study of twenty-five consective patients. Asian Pac J Cancer Prev, 16, 5319-23.
  3. Bonney PA, Boettcher LB, Krysiak RS 3rd, et al (2015). Fung KM, Sughrue ME. Histology and molecular aspects of central neurocytoma. Neurosurg Clin N Am, 26, 21-9.
  4. Brat DJ. Neuronal and Glioneuronal Neoplasms. In Perry A, Brat DJ eds (2010). Practical Surgical Neuropathology. A diagnostic approach . Churchill Livingstone Elsevier Inc Philadelphia, PA, 125-50.
  5. Canova CH, Riet FG, Idbaih A, et al (2014). Radiotherapy in central neurocytoma and review of literature. Cancer Radiother, 18, 222-8.
  6. Chen CL, Shen CC, Wang J, et al (2008). Central neurocytoma: a clinical, radiological and pathological study of nine cases. Clin Neurol Neurosurg, 110, 129-36.
  7. Chen CM, Chen KH, Jung SM, et al (2008). Central neurocytoma: 9 case series and review. Surg Neurol, 70, 204-9.
  8. Chen H, Zhou R, Liu J, et al (2012). Central neurocytoma. J Clin Neurosci, 19, 849-53.
  9. Chen WJ, He DS, Tang RX, et al (2015). Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis. Asian Pac J Cancer Prev, 16, 411-20.
  10. Chou YY, Lee CC, Chen TJ, et al (1999). Atypical central neurocytoma: report of a case. J Formos Med Assoc, 98, 573-7.
  11. Choudhari KA, Kaliaperumal C, Jain A, et al (2009). Central neurocytoma: a multi-disciplinary review. Br J Neurosurg, 23, 585-95.
  12. Conrad MD, Morel C, Guyotat J, et al (2000). Central nervous system neurocytomas: clinicopathological analysis of tree cases. Arq Neuropsiquiatr, 58, 1100-6.
  13. Dodero F, Alliez JR, Metellus P, et al (2000). Central neurocytoma: 2 case reports and review of the literature. Acta Neurochir (Wien), 142, 1417-22.
  14. Favereaux A, Vital A, Loiseau H, et al (2000). Histopathological variants of central neurocytoma: Report of 10 cases. Ann Pathol, 20, 558-63.
  15. Figarella-Branger D, Pellissier JF, Daumas-Duport C, et al (1992). Central neurocytomas. Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol, 16, 97-109.
  16. Figarella-Branger D, Soylemezoglu F, Burger PC (2007). Central Neurocytoma and extraventricular neurocytoma. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumors of the Central Nervous System. 4th Edition. IARC, Lyon, 106-9.
  17. Gultekin SH, Dalmau J, Graus Y, et al (1998). Anti-Hu immunolabeling as an index of neuronal differentiation in human brain tumors: a study of 112 central neuroepithelial neoplasms. Am J Surg Pathol, 22, 195-200.
  18. Hassoun J, Gambarelli D, Grisoli F, et al (1998). Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol, 56, 151-6.
  19. Hassoun J, Soylemezoglu F, Gambarelli D, et al (1993). Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol, 3, 297-306.
  20. Kane AJ, Sughrue ME, Rutkowski MJ, et al (2012). Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg, 116, 349-54.
  21. Kawano H, Kimura T, Iwata K, et al (2015). Atypical extraventricular neurocytoma in a 3-year-old girl: case report with radiological-pathological correlation. Childs Nerv Syst, 31, 1189-93.
  22. Mackenzie IR (1999). Central neurocytoma: histologic atypia, proliferation potential, and clinical outcome. Cancer, 85, 1606-10.<1606::AID-CNCR24>3.0.CO;2-B
  23. Patil AS, Menon G, Easwer HV, et al (2014). Extraventricular neurocytoma, a comprehensive review. Acta Neurochir, 156, 349-54.
  24. Preusser M, Budka H, Rossler K, et al (2007). OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms. Histopathol, 50, 365-70.
  25. Robbins P, Segal A, Narula S, et al (1995).Central neurocytoma. A clinicopathological, immunohistochemical and ultrastructural study of 7 cases. Pathol Res Pract, 191, 100-11.
  26. Sharma MC, Deb P, Sharma S, et al (2006). Neurocytoma: a comprehensive review. Neurosurg Rev, 29, 270-85.
  27. Soylemezoglu F, Scheithauer BW, Esteve J, et al (1997). Atypical central neurocytoma. J Neuropathol Exp Neurol, 56, 551-6.
  28. Soylemezoglu F, Onder S, Tezel GG, et al (2003). Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma. Pathol Res Pract, 199, 463-8.
  29. Sweiss FB, Lee M, Sherman JH (2015). Extraventricular neurocytomas. Neurosurg Clin N Am, 26, 99-104.
  30. Tacconi L, Thom M, Symon L (1997). Central neurocytoma: a clinico-pathological study of five cases. Br J Neurosurg, 11, 286-9.
  31. Trabelsi S, Brahim DH, Ladib M, et al (2014). Glioma Epidemiology in the Central Tunisian Population:1993-2012. Asian Pac J Cancer Prev, 15, 8753-7.
  32. Ulivieri S, Oliveri G (2007). Intraventricular neurocytoma: case report. Pathologica, 99, 309-12.
  33. von Deimling A, Janzer R, Kleihues P, et al (1990). Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol, 79, 473-9.
  34. Vrana D, Cwiertka K, Lukesova L, et al (2013). Patient with atypical neurocytoma -case report. Klin Onkol, 26, 362-4.
  35. Yang I, Ung N, Chung LK, et al (2015). Clinical manifestations of central neurocytoma. Neurosurg Clin N Am, 26, 5-10.
  36. Zahir ST, Vakili M, Navabii H, et al (2014). Clinicopathological findings and five year survival rates for patients with central nervous system tumors in Yazd, Iran. Asian Pac J Cancer Prev, 15, 10319-23.

Cited by

  1. Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience pp.1573-7373, 2018,